Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Consolidated Standards of Reporting Trials flowchart of study inclusion criteria.

More »

Fig 1 Expand

Table 1.

Sociodemographic and clinical characteristics of patients receiving chemotherapy versus Non-chemotherapy in PC patients.

More »

Table 1 Expand

Table 2.

Multivariate Logistic regression model to predict chemotherapy or non-chemotherapy in PC patients.

More »

Table 2 Expand

Fig 2.

Cumulative incidence plots in the original cohort showed HSM and OCM rates in PC patients.

More »

Fig 2 Expand

Fig 3.

Density plots of propensity score before (A) and after matching

(B).

More »

Fig 3 Expand

Fig 4.

After 1:1 propensity score matching, Cumulative incidence plots showed HSM and OCM rates in PC patients with or without chemotherapy.

More »

Fig 4 Expand

Table 3.

Propensity score-adjusted competing risk model predict Heart-specific mortality and other causes mortality in PC patients.

More »

Table 3 Expand

Fig 5.

(A) Standardized mean difference distribution of patients after the inverse probability of treatment weighting matching. (B)Kaplan-meier curve of PC patients with or without chemotherapy.

More »

Fig 5 Expand